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Abstract We have developed a mathematical model that 
allows simulation of oxygen distribution in a bone defect as 
a tool to explore the likely effects of local changes in cell 
concentration, defect size or geometry, local oxygen 
delivery with oxygen-generating biomaterials (OGBs), and 
changes in the rate of oxygen consumption by cells within 
a defect. Experimental data for the oxygen release rate 
from an OGB and the oxygen consumption rate of a 
transplanted cell population are incorporated into the 
model. With these data, model simulations allow prediction 
of spatiotemporal oxygen concentration within a given 
defect and the sensitivity of oxygen tension to changes in 
critical variables. This information may help to minimize 
the number of experiments in animal models that determine 
the optimal combinations of cells, scaffolds, and OGBs in 
the design of current and future bone regeneration strate-
gies. Bone marrow-derived nucleated cell data suggest that 
oxygen consumption is dependent on oxygen concentra-
tion. OGB oxygen release is shown to be a time-dependent 
function that must be measured for accurate simulation. 
Simulations quantify the dependency of oxygen gradients 
in an avascular defect on cell concentration, cell oxygen 
consumption rate, OGB oxygen generation rate, and OGB 
geometry. 
Keywords Oxygen consumption  Bone defect  
Oxygen tension  Tissue engineering  Mathematical 
modeling 
1 Introduction 
Effective tissue regeneration in a bone defect is clinically 
essential in many settings of high-energy trauma in order to 
return patients to full mobility and productive life. Bone 
formation requires the contribution of osteogenic (bone 
forming) connective tissue progenitors (CTP-Os). CTP-Os 
represent a heterogeneous population of cells resident in 
bone marrow, periosteum, and other tissues that are capable 
of proliferating and differentiating into one or more con-
nective tissues [13, 14]. In many clinical settings, such as 
fracture nonunion and bone defects, the local population of 
CTP-Os is suboptimal [3]. In these settings, transplantation 
of bone marrow-derived osteoblastic stem and progenitor 
cells is a promising therapeutic strategy. However, oxygen 
tension within a site where CTP-Os are transplanted is a 
critical determinant of cell survival and cell fate. 
CTP-Os can be readily harvested from bone and marrow 
tissues. In clinical practice, they are transplanted in the 
form of cancellous autograft bone or bone marrow aspi-
rates and are often combined with biocompatible scaffolds 
[2, 16]. However, the environments in which these grafts 
are placed are often characterized by profound hypoxia, 
which limits the likely survival of transplanted cells. As a 
result, optimization of the effectiveness of such cell 
transplantation in the setting of bone defects and other 
tissue engineering constructs must be informed by a keen 
awareness and understanding of the biological environment 
into which CTP-Os and other cells are placed, particularly 
with respect to hypoxia [13, 23]. 
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In theory, the oxygen tension environment within a bone 
defect can be modulated by many interacting factors, 
including the vascularity of surrounding tissues, the local 
concentration of cells in the defect, the rate of oxygen 
consumption by cells within a defect, defect size or 
geometry, and the diffusion or convection path that is 
available for fuid and therefore dissolved oxygen transport 
through the defect. Several studies have suggested that 
oxygen tension and the outcome of tissue formation can 
also be infuenced by local oxygen delivery within the 
defect, using oxygen-generating biomaterials (OGBs) [1, 6, 
17, 18, 24]. 
The goal of this project was to develop a mathematical 
model to simulate oxygen distribution in an established 
in vivo bone defect [15, 22] as a tool to inform and 
accelerate the optimization of cell therapy strategies and 
possible use of OGBs. This model is used to explore the 
relative effects of variation in defect size and OGB 
geometry, the number of cells, the oxygen consumption 
rate of transplanted cells, and the oxygen release rate from 
an OGB. This information is essential to minimize the 
number of experiments in an animal model that determine 
the optimal combinations of scaffold, OGB, and cell con-
centration, thus shortening the amount of time from bench 
to bedside in developing new therapies. 
Previous models have defned oxygen consumption [7– 
10, 25, 28] and oxygen transport [9, 12, 14, 28] in tissues, but 
these models are not designed to inform the sensitivity to 
variables that may be manipulated in an established pre-
clinical animal model to enhance clinical success. In the 
following sections, we frst describe the design and devel-
opment of the mathematical model, followed by experi-
mental studies that were performed to provide objective data 
on the oxygen consumption rates of the progeny of human 
bone marrow-derived CTP-Os and oxygen generation rates 
for gas-foamed cylinders of OGB. These experimental data 
provide a clinically relevant set of parameters that enable 
examination of the effect of cell number and other parame-
ters, which are presented in subsequent sections. 
2 Methods 
2.1 Model development 
Our general approach was to simulate the dynamic oxygen 
concentration distribution in an avascular cylindrical bone 
defect [15, 22]. The major components that determine the 
oxygen concentration in such a defect include the sur-
rounding vascularized tissues, the cell-seeded scaffold 
implanted in the defect, and the OGBs implanted in the 
center of the cell-seeded scaffold. The key model param-
eters relate to the defect size, scaffold size, transplanted 
cell density, transplanted cell oxygen consumption rate, 
and OGB oxygen release rate. Though we apply this model 
to a cylindrical avascular bone defect, this model can be 
modifed to apply to any defect size, transplanted cell 
population, OGB, and tissue site. 
A mathematical model was developed that describes mass 
transport of oxygen in a cell-seeded scaffold occupying an 
avascular bone defect. In the scaffold, it is assumed that the 
number of cells remains constant and that the cells are dis-
tributed uniformly. Consequently, the oxygen consumption 
rate is also spatially uniform. Following previous experi-
ments [15, 20, 22, 26, 27], the annular space of the scaffold 
(Fig. 1) is axially symmetric. The dominant transport pro-
cess in the avascular annular space is diffusion of oxygen in 
the radial direction. In the animal model simulated [15, 22], 
negligible diffusion occurs axially either through the cortical 
bone at the bottom of the defect or through the fxation plate 
that covers the top of the defect. Convection is deemed 
negligible in the absence of a vasculature and with only 
minimal and irregular convection possible due to the 
mechanical environment of the defect. Thus, the molar 
concentration of oxygen changes according to:   
oC 1 o oC ¼ D r  NRðCÞ ð1Þ 
ot r or or 
where C is the oxygen concentration (lmol ml -1), r is the 
radial distance from the center of the cylinder (cm), D is a 
h -1constant diffusion coeffcient (cm2 ), R(C) is the 
oxygen consumption rate per cell [lmol h -1 
(106 cells) -1], and N is the number of cells per unit 
volume in the scaffold (cells ml -1). The initial condition 
assumes that the oxygen in the scaffold surrounded by the 
OGB is in equilibrium with the environment: 
t ¼ 0 : C ¼ Cair ð2Þ 
This is the oxygen concentration of room air 
corresponding to that in an open wound at the time of 
surgery. At the boundary of the scaffold and OGBs, the rate 
of oxygen generation equals the rate of diffusion: 
oC 
r ¼ rOGB : SD ¼ VGðtÞ ð3Þ or 
Here, S is the surface area at rOGB (cm
2) and V is the 
volume occupied by the OGBs (ml) so that V/S = rOGB/2. 
Oxygen generation is assumed to be occurring 
homogenously over the entire lateral surface area (S) of  
the OGB. At the boundary of the scaffold and the 
vascularized bone tissue, the oxygen is in local 
equilibrium, so that its concentration is as follows: 
r ¼ rbone : C ¼ Cbone ð4Þ 
The volume of the vascularized bone surrounding the 
avascular defect is suffciently large relative to the volume 
 Fig. 1 Model geometry: a from 
left to right: Photograph of 
canine femoral defect creation 
using a custom drill guide, 
defect creation, and CTP-loaded 
scaffold containing oxygen-
generating biomaterials 
(OGBs). b Geometry of defect. 
Dark: Scaffold with CTPs. 
White: OGB with no cells. 
c Radial cross section of defect 
in bone 
of the avascular defect such that the concentration of 
oxygen in the vascularized bone is assumed constant. 
2.2 Oxygen generation from oxygen-generating 
biomaterial (OGB) 
Gas foaming was used to fabricate cylindrical OGBs 
composed of poly(lactic-co-glycolic acid) (PLGA) (DU-
RECT, Birmingham, AL) and sodium percarbonate (SPC) 
(Sigma Aldrich, St. Louis, MO) using published methods 
[5, 21]. The PLGA used has a lactide-to-glycolide ratio of 
50:50. PLGA and SPC were ground to a size range of 
106–250 lm and 1–63 lm, respectively, mixed at a mass 
ratio of 70:30, placed in a 3-mm die, pressed with 1.5 tons 
of pressure, and transferred to a pressure cylinder. The 
composite was infused with CO2 at 800 psi and held for 
20 h. Pressure was then rapidly released over 1 min caus-
ing a thermodynamic instability that fuses the PLGA par-
ticles together, encapsulating the SPC particles within the 
bulk PLGA cylinder and resulting in an OGB cylinder 
3 mm in diameter and 15 mm tall. 
In vitro oxygen release from the OGB was measured 
using fve oxygen microelectrodes (Strathkelvin Model 
#1302) ftted into a RC650 respirometer (Strathkelvin 
Instruments, Ltd., North Lanarkshire, Scotland). OGB 
cylinders were placed in three respirometry wells, and 
control cylinders fabricated with PLGA only were placed 
in two separate wells. All wells were flled with sterile 
water. Wells were sealed and mixed with a microstir bar to 
prevent bubble formation from the oxygen-generating 
reaction. All fve wells were housed within the same 
temperature-controlled water bath set at 37 C to minimize 
well-to-well variation in temperature fuctuation. Oxygen 
concentration was measured continuously for 4 days. 
Variation in data collection from electrode to electrode was 
controlled by performing simultaneous calibration on all 
electrodes prior to each experiment to ensure accurate 
measurement. Calibration was checked at the conclusion of 
data collection to ensure minimal drift of electrode signal 
throughout the experiment. 
The respirometry wells were opened every 12 h and 
allowed to equilibrate with room air (Co = 0.341 lmol 
ml -1) for the frst 48 h to prevent oxygen from accumu-
lating to a concentration above the dynamic range of the 
electrodes. The left panel of Fig. 2 shows the average 
oxygen concentration h CkðtiÞi (lmol ml -1) for each 12-h 
interval (ti) within each well. Data are presented for each of 
three water samples containing OGB with SPC (k = 1) and 
each of two water samples containing PLGA only (k = 2). 
From the average oxygen concentration h CkðtiÞi 
(lmol ml -1), the average oxygen accumulation, Gk, per 
h -1unit volume (lmol ml -1 ) of k for 12-h intervals 
(ti?1 - ti, i = 0, 1, 2,…8) is: (   
Vwater h Ckðtiþ1Þi  Co Co ¼ 0:341; 0  t  48 
Gk ¼ ; 
Vk tiþ1  ti Co ¼ h CkðtiÞi; 48  t  96 
ð5Þ 
where Vwater is the volume of water in the well (ml) and Vk 
is the volume of k (ml). The true oxygen generation rate per 
h -1unit volume of OGBs, G (lmol ml -1 ), is the 
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Fig. 2 Oxygen release from oxygen-generating biomaterials (OGBs). 
Left: Oxygen concentration in respirometer from OGB (solid symbols) 
or PLGA only (open symbols). Different symbol shapes represent data 
from each individual well. Center: Oxygen release rate as a function 
difference between the rates of accumulation from OGB 
(G1) and PLGA (G2): 
GðtÞ ¼ G1  G2 ð6Þ 
The center panel of Fig. 2 shows this average rate of 
oxygen generation per unit volume of the OGBs for the 
eight intervals and the representation of these data as a 
continuous, piecewise linear function: 
GðtÞ ¼ at þ b 8 > ð5:3  104Þ t; 0  t  54 < 
¼  ð1:3  103Þ t þ 0:098; 54  t  75 ð7Þ > : ð6:0  105Þ t  3:8  103; 75  t  96 
Piecewise linear segments were chosen as the simplest 
and best model ft to the three distinct phases of oxygen 
generation. The frst segment, constrained to zero to 
prevent negative generation values for simulation, had a 
R2 coeffcient of determination of = 0.847. Each 
subsequent linear segment was constrained to the 
intersection point of the previous segment to ensure a 
continuous function as required for simulation. The 
coeffcients of determination for these two segments were 
R2 = 0.952 and 0.999, respectively. The parameters ft to 
this model along with the 95 % confdence interval for 
each parameter are as follows: 
0  t  54 : a ¼ 5:32  104 ½3:24  104; 7:40  104 
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of time (triangles: calculated derivative of oxygen concentration 
versus time data, line: piecewise ft of derivative data to three linear 
segments). Right: cumulative oxygen release as a percentage of the 
total oxygen released over the duration of the experiment versus time 
54  t  75 : 
a ¼ 1:32  103 ½5:11  103; 2:47  103 
b ¼ 9:77  102 ½1:33  101; 3:28  101 
75  t  96 : a ¼ 5:99  105 ½3:73  105; 8:26  105 
b ¼ 3:77  103 ½5:69  103; 1:86 
 103 
Integration of G(t) over time yields the cumulative 
oxygen generation (right panel). This emphasizes that more 
than 90 % of the oxygen generated during the experiment 
occurred in the frst 48 h. 
2.3 Tissue harvest, cell isolation, and cell culture 
Discarded cancellous bone that was removed from the 
proximal femur from a human patient (male, age 64) 
undergoing an elective hip arthroplasty procedure was used 
as the cell source in a protocol approved by the Cleveland 
Clinic Institutional Review Board. Cancellous bone was 
minced with an osteotome into pieces no larger than 1 mm 
in any dimension and transferred to a 50-ml tube containing 
10 ml of a-MEM (Sigma Aldrich, St. Louis, MO). The 
sample was inverted by hand 50 times, allowed to settle, and 
then inverted an additional 50 times to remove all suspended 
and loosely adherent cells from the pieces of bone. The 
supernatant was collected and passed through a 70-lm nylon  
cell strainer (BD Biosciences, San Jose, CA) to remove bone 
chips and other debris. The resultant cell fraction was cen-
trifuged at 4009g for 10 min, and the supernatant was 
removed. The pellet was resuspended in 20 ml of osteogenic 
media comprising a-MEM (Sigma Aldrich, St. Louis, MO), 
10 % fetal bovine serum (Cambrex, Walkersville, MD), 
sodium ascorbate (50 lg ml  -1) (Sigma Aldrich, St. Louis, 
MO), 1 % antibiotic/antimycotic (Gibco, Grand Island, NY), 
and 10 -8 M dexamethasone (Sigma Aldrich, St. Louis, 
MO). Twelve-millimeter glass coverslips were sterilized by 
soaking in 70 % EtOH for 30 min followed by 30 min of 
exposure to UV radiation. The cell suspension was diluted 
accordingly and plated immediately on the coverslips at a 
density of 4.42 9 105 cells cm -2. Medium was changed 
twice per week, and cells were observed on a bright-feld 
microscope for confuence. Coverslips were used for respi-
rometry when a qualifed microscopist confrmed that cells 
had achieved 70 % confuence. 
2.4 Cellular oxygen consumption 
Closed-cell respirometry was used to measure both the 
consumption of oxygen by bone marrow-derived mono-
nuclear cells and the release of oxygen from OGBs. 
Closed-cell respirometry was performed using a Strath-
kelvin 6 Electrode Respirometer ftted with six Strathkelvin 
1302 Oxygen Electrodes with polypropylene membranes 
and controlled using a Strathkelvin Model 929 6-Channel 
Oxygen Meter (Warner Instruments, Hamden, CT). Each 
chamber is a closed environment in which no oxygen is 
allowed in or out. All measurements began at room air 
(O2 = 21 % = 0.341 lmol ml 
-1). 
To measure cell consumption, 12-mm-diameter circular 
coverslips containing adherent primary bone marrow-
derived nucleated cells (cultured as described above) were 
placed in four respirometry wells as shown in Fig. 3a. The 
remaining two wells contained sterile 12-mm coverslips 
without cells. All wells were flled with a-MEM (Sigma 
Aldrich, St. Louis, MO) supplemented with 20 mM 
HEPES (Sigma Aldrich, St. Louis, MO). Wells were 
sealed, and oxygen concentration was measured until all 
cell-containing wells reached \1 % oxygen. At the con-
clusion of the experiment, coverslips were stained for 
nuclei using 40 , 6-diamidino-2-phenylindole (DAPI) 
(Vector Labs, Burlingame, CA). Coverslips were then 
imaged with a fuorescent microscope as seen in Fig. 3b, 
and a cell count was obtained for each coverslip as previ-
ously described by Powell et al. [19] using the ColonyzeTM 
analysis software. Oxygen consumption rate was calculated 
as a function of oxygen concentration by taking the 
derivative of the oxygen concentration as a function of 
time. The oxygen consumption rate was normalized on a 
per-cell basis using the cell count from each coverslip. 
Fig. 3 Respirometry system: a Respirometry well with oxygen 
microelectrode above a confuent cell layer on a coverslip. b Fluores-
cent image of nuclei stained with DAPI 
Fig. 4 Oxygen consumption rate of bone marrow-derived nucleated 
cells: best-ft curve (black line) of saturation kinetics model to data 
(diamonds) (N = 4). R2 = 0.81 
h -1The oxygen consumption rate R (lmol cell -1 ) of  
nucleated cells derived from bone marrow is dependent on 
the oxygen concentration C (lmol ml -1) in the surround-
ing environment (Fig. 4). The rate of oxygen consumption 
increased as a function of oxygen concentration up to 
0.162 lmol ml -1 and leveled off as oxygen continued to 
increase. To represent the saturation kinetics of these data, 
we applied a Michaelis–Menten-like model to describe 
how the oxygen consumption rate varies according to our 
experimental data (R2 = .704) as: 
aC 69:2C 
RðCÞ ¼ ¼ ð8Þ 
b þ C 2:46  102 þ C 
The parameters ft to this model along with the 95 % 
confdence interval for each parameter are as follows: 
a ¼ 69:2 ½53:3; 85:1 
b ¼ 2:46  102 ½1:125  104; 4:90  102 
  
3 Results 
3.1 Experimental results 
The OGB was shown to generate oxygen over a period of 
48–60 h. Figure 2 demonstrates that over 90 % of the total 
oxygen generated was released in the frst 48 h. Oxygen 
accumulation was observed in chambers containing OGBs 
as well as PLGA cylinders during the frst 48 h. After 48 h, 
OGBs continued to accumulate oxygen, while the PLGA 
cylinders ceased oxygen accumulation. This phenomenon 
is likely due to the release of air trapped in the materials 
during gas foaming (cylinders in both cases initially foated 
to the top of the respirometry chamber). Despite any 
accumulation seen in PLGA chambers, OGB chambers 
generally had signifcantly higher rates of accumulation. 
These data indicate that oxygen generation is occurring in 
addition to the release of trapped air during the frst 48 h of 
the experiment. The variability in magnitude of oxygen 
generation between each OGB is likely due to the vari-
ability in the volume and distribution of trapped air. In 
some instances, decreases in oxygen concentration (i.e., 
‘‘negative’’ oxygen generation or oxygen consumption) 
were observed. This is likely not oxygen consumption, but 
rather the result of temperature fuctuations in the water 
bath, since the control wells (PLGA) always exhibited 
larger decreases in oxygen than the OGB wells over the 
same time intervals. To computationally defne the oxygen 
generation by OGBs, the average oxygen release from 
PLGA cylinders was subtracted from that of OGBs (Eq. 6). 
In vivo, the combination of air trapped in the PLGA phase, 
as well as chemical production of oxygen by sodium per-
carbonate encapsulated in OGBs (represented by G1), 
would lead to even further oxygen delivery than that 
reported in G(t) (Eq. 7). The dynamic range of the elec-
trodes was limiting due to the rapid accumulation of oxy-
gen at early time points. Though not ideal, opening of the 
chambers to room air at defned intervals allowed for 
continued quantifcation of oxygen accumulation by 
avoiding electrode limitations. 
Oxygen consumption of CTPs and their progeny 
depends on oxygen concentration. Oxygen consumption of 
bone marrow-derived nucleated cells varies signifcantly as 
a function of oxygen tension. The data in Fig. 4 demon-
strate that the oxygen consumption rate tends to increase 
with oxygen tension in bone marrow-derived nucleated 
cells commonly used for therapy. Similar dependency of 
oxygen consumption rate on oxygen tension has been 
observed in other cell populations [7, 8, 25]. Initially, these 
cells consume oxygen at very low levels given the low 
oxygen concentrations in the avascular defect. As oxygen 
is released from the OGBs and as oxygen diffuses in from 
surrounding tissues, oxygen levels rise, and Fig. 4 shows 
that cells consume increasingly more oxygen until con-
sumption rates level off at approximately 7–10 % 
(0.11–0.16 lmol ml -1) of oxygen. These data suggest that 
cells have the ability to regulate their consumption in order 
to acclimatize to their surrounding oxygen environment. 
Consequently, it is essential to include in the model the 
dependence of cellular oxygen consumption rate on oxygen 
concentration. 
3.2 Simulation results 
In addition to the empirical functions G(t) and R(C), Eqs. 7 
and 8, respectively, the values of all model parameters used 
for model simulation are specifed in Table 1. Since the 
parameters N and a always appear as a product in this 
model, the effect of these parameters on the model output 
cannot be distinguished. The value for D at 37 C was 
calculated using interpolation of empirical values for 
oxygen in water [4]. Values of the geometric parameters 
were taken from experimental studies [15, 22]. The model 
involving a partial differential equation was solved 
numerically using the MATLAB algorithm, ‘‘pdepe’’, to 
obtain the dynamic changes in the O2 concentration dis-
tribution between an OGB placed in the center of the defect 
and the bone at the periphery of the defect. Simulations 
were performed to demonstrate the spatiotemporal output 
of the model, as well as the sensitivity of the model to 
variable parameters. 
OGBs almost always exhibit a nonlinear release profle 
with some degree of burst release followed by a more 
stable release rate over a defned time period. Under con-
ditions specifed in Table 2, panels A, B, and C in Fig. 5 
demonstrate the change in radial distribution of oxygen 
throughout the defect over 96 h corresponding to the 
release rate of oxygen from OGB in the center of the defect 
Table 1 Model parameters 
Parameters Description Quantity 
rOGB (cm) Radius of oxygen-generating 0.15 
biomaterial 
rbone (cm) Radius of avascular bone defect 0.5 [22] 
N (cells ml -1) Number of cells per unit volume 9.31 9 105 
in the defect 
h -1D (cm2 ) Diffusion coeffcient of oxygen 0.136 [4] 
in water at 37 C 
Cair (lmol ml 
-1) Concentration of oxygen in air 3.41 9 10 -1 
Cbone (lmol ml 
-1) Concentration of oxygen in 5.82 9 10 -2 
vascularized bone tissue [11] 
Vwater (ml) Volume of water in the 2 
respirometry well 
Table 2 
values 
Simulation parameter 
Simulation # N (106 cells ml -1) a (unitless) rOGB (mm) Vwater/Vk (unitless) Output 
1 0.1 1 15 1 Fig. 5 
2 0.5 1 15 1 Fig. 6a 
3 0.1 1 15 1 Fig. 6a 
4 0.25 1 15 1 Fig. 6a 
5 0.1 5 15 1 Fig. 6b 
6 0.1 1 15 1 Fig. 6b 
7 0.1 0.25 15 1 Fig. 6b 
8 0.1 1 7.5 1 Fig. 6c 
9 0.1 1 15 1 Fig. 6c 
10 0.1 1 25 1 Fig. 6c 
11 0.1 1 15 5 Fig. 6d 
12 0.1 1 15 1 Fig. 6d 
13 0.1 1 15 0.25 Fig. 6d 
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Fig. 5 Model output as a spatiotemporal change in oxygen concentration: Under conditions specifed in Table 2, this simulation demonstrates 
the effect of a time-dependent oxygen generation function (d, e, and f) on the radial distribution of oxygen in the defect over time (a, b, and c) 
(D, E, and F, respectively). Oxygen levels are observed to 
increase throughout the defect (A) as the OGB oxygen 
release rate increases from 0 to 48 h (D). Conversely, 
oxygen levels are observed to decrease (B) as the oxygen 
release rate decreases from 48 to 72 h (E). Little to no 
change in radial oxygen distribution is observed as the 
OGB oxygen release rate remains relatively low and con-
stant (C) from 72 to 96 h (F). 
The simulation in Fig. 5 demonstrates how a time-
dependent oxygen generation function affects the radial 
distribution of oxygen in the defect changes over time. 
Consequently, the model can be used to predict the spatial 
distribution of oxygen in the defect over time in 
conjunction with experiments in which key parameters are 
controlled. As the rate of generation, G(t), increased, a 
progressively larger fraction of the defect received suff-
cient oxygen in areas adjacent to the OGB. Conversely, the 
distribution of oxygen in the defect falls as the generation 
rate decreases. The temporal changes in oxygen distribu-
tion due to OGB release are modulated by the concentra-
tion-dependent oxygen consumption. At low generation 
rates (e.g., 72 h), oxygen consumption remains negligible 
due to minimal oxygen accumulation so that the generation 
rate still dominates. High oxygen generation rates (e.g., 
48 h) cause signifcant oxygen accumulation leading to 
increased contribution of the oxygen consumption due to 
higher oxygen concentrations. Under this condition, the 
negative feedback loop of oxygen concentration-dependent 
consumption prevents runaway oxygen accumulation. 
The simulations in Fig. 6 illustrate the predicted sensi-
tivity of the distribution of oxygen to changes in N (cell 
concentration, (106 cells ml -1)) and a (consumption rate, 
unitless), rOGB (i.e., radius (mm)), and Vwater/Vk (relative 
oxygen generation rate, unitless). Parameter ranges were 
selected to refect reasonable physiological and experi-
mental values that demonstrate signifcant changes in 
oxygen distribution within the defect. A parabolic-like 
distribution is evident in all simulations. Analysis of the 
sensitivity to cell concentration predicts that oxygen ten-
sion midway between the OGB surface and the vascular-
ized surface of the defect would fall to near anoxic levels at 
48 h unless the concentration of cells in the defect was 
reduced to below 100,000 cells ml -1. A fourfold reduction 
in consumption rate could also infuence oxygen tension, 
but only in the setting of cell concentrations at or near 
100,000 cells ml -1. Similarly, increasing oxygen genera-
tion fvefold could increase the minimum oxygen concen-
tration signifcantly, but again, only in this critical range of 
cell concentrations. 
4 Discussion 
4.1 Simulations to quantify critical parameters 
Simulations of this model can serve as a valuable tool to 
explore and understand the implications of changes in cell 
concentration, consumption, and oxygen delivery in a 
defned bone defect site. These data focus attention on the 
critical variable of cell concentration as a principle deter-
minant of local oxygen tension within a defect site. Based 
on measured parameters of oxygen consumption and oxy-
gen generation with our example OGB, these data suggest 
that therapeutic strategies that involve the delivery of 
transplanted cells at a concentration of 100,000 cells ml -1 
or less may be necessary to optimize cell survival. Math-
ematical models are necessary to make more effcient the 
task of optimizing the large number of parameters in the 
design of a tissue engineering construct. A signifcant time 
and cost savings can be realized through simulation of an 
in vivo defect rather than through experimentation only. 
4.2 Model validity 
Assumptions applied in model derivation impact the sim-
ulation results. The degree to which each assumption 
affects the outcomes is important to consider. The 
assumption that no cell death is occurring has perhaps the 
most signifcant effect on simulation results. When oxygen 
tensions drop to anoxic levels, cells are assumed to be 
consuming little to no oxygen. In vivo, these cells would 
likely undergo hypoxia-induced apoptosis. However, with 
the assumption of no cell death, these cells are capable of 
consuming oxygen at later simulation time points as oxy-
gen returns to these formerly anoxic regions. Although 
subpopulations of transplanted cells will be resistant, or 
even stimulated, at low oxygen tensions, the net effect of 
this assumption is likely an overestimation of cell oxygen 
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simulation parameters are defned in Table 2 
consumption and a possible underestimation of how few 
cells need to be transplanted in order to have a fully oxy-
genated defect. 
The assumption of no proliferation or infammatory 
invasion also affects simulation results. In vivo, there is 
likely some degree of proliferation and infammatory 
response. By keeping the number of cells constant in 
simulations, cellular consumption is likely underestimated 
and the resultant prediction of oxygen levels in the defect is 
likely overestimated. As indicated previously, model sim-
ulations show the greatest sensitivity to changes in cell 
concentration. Overall, the assumptions of no cell death or 
proliferation and no infammatory response are special 
cases. If suffcient data were available, these additional 
processes could also be simulated. However, the overall 
effect of these cellular changes is likely more neutral since 
the reduction in cells within the defect due to cell death is 
offset by the addition of cells due to infammatory cells or 
cell proliferation. The balance between the addition and 
loss of cells will depend largely on the initial cell con-
centration, which would increase cell loss in the center, and 
the magnitude of the infammatory response, which would 
add cells to the periphery. This combination of events will 
erode the assumption of a uniform distribution of cells. As 
a result, the decline in actual oxygen tension at the 
periphery of the defect may be steeper than predicted, 
while the decline in oxygen moving away from the OGB 
may be less. These effects may shift the oxygen distribu-
tion to the right. 
4.3 Model fexibility for a wide variety of clinical 
applications 
This model incorporates defect and scaffold sizes, cellular 
oxygen consumption rates, cell concentrations, neighboring 
tissue oxygen concentration, and OGB production rates. 
Since it accommodates so many construct design parame-
ters, it can simulate a variety of clinically relevant situa-
tions. We chose the minimum number of parameters that 
can be measured independently prior to implantation. In 
order to simulate a specifc set of in vivo phenomena, these 
parameters characterize the defect and the construct placed 
in that defect. Simulations can minimize the time and effort 
to design and fabricate a customized therapeutic populated 
with the appropriate amount of cells and oxygen-generat-
ing materials for a given defect. Although this model does 
not take into consideration cell proliferation and apoptosis 
as variables, it is expected that their contributions are rel-
atively small. 
Based on the principles of mass transport and reaction 
processes, this model can easily be adapted and applied to 
other tissue types. For application to bone defects, the 
model incorporates diffusion, generation, consumption, 
and oxygen from surrounding tissues in a closed system. 
For vascularized tissues, the model would include con-
vection, and for an epithelial sheet of cells, oxygen con-
sumption may not be homogenous. 
4.4 Acceleration of OGB development 
Simulations with this model may accelerate development 
of OGBs with novel biomaterials. The data in Fig. 2 
demonstrate the effcacy of OGBs in delivering oxygen 
suffcient for approximately 105 cells for up to 4 days. 
Previous work demonstrates the possibility of producing 
oxygen in signifcant concentrations on the order of weeks 
to months using similar materials [1, 5, 14, 15]. Once a 
target defect and therapeutic cell population has been 
selected, this model can be used to identify the benchmarks 
(delivery magnitude, delivery rate, cell distribution, 
geometry, etc.) necessary to create an ideal biomaterial for 
the defect. This will speed development of new materials 
from bench to bedside through minimization of in vitro 
experiments, decreased time and cost of animal studies, 
and an overall streamlined path to clinical trials. 
4.5 Future studies 
Model simulations can help defne the type of critical 
experiments necessary for designing therapeutic OGBs and 
cell-loaded constructs. The transplanted cell population 
must be characterized empirically in order to determine the 
rate at which cells consume oxygen and how this rate 
depends on the oxygen concentration in the surrounding 
environment. Then, model simulations can identify a 
proper combination of OGB size and oxygen generation 
rate to address a given defect and transplanted cell popu-
lation. The results will serve as a benchmark for OGB 
design. 
4.6 Conclusions 
The mathematical model developed in this study can pre-
dict the oxygen distribution for tissue regeneration in a 
bone defect. This model allows systematic exploration of 
the likely sensitivity of local oxygen tension to changes in 
the concentration of cells transplanted, the defect size and 
geometry, the rate of oxygen delivery in the defect, and the 
mean oxygen consumption per cell. Simulations highlight 
the critical parameter of cell concentration N in determin-
ing the oxygen concentration throughout the defect. 
Although changing a has the same effect as changing N, 
the value of a is an intrinsic property of the system and 
cannot be externally modulated as can be done with 
N. Oxygen consumption of bone marrow-derived nucleated 
cells is dependent on oxygen concentration and decreases 
as oxygen tension falls below 0.05 lmol ml -1. Oxygen 
release from OGBs may be considered as a means of 
modulation of local oxygen tension in a defect site, rec-
ognizing that oxygen release is a time-dependent function 
that must be measured for accurate simulation. 
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